Related Experiment Video
Updated: Jul 2, 2026
09:44
Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
Eicosanoids in tumor progression and metastasis.
Sriram Krishnamoorthy1, Kenneth V Honn
1Departments of Pathology, and Chemistry, Wayne State University School of Medicine, Detroit, MI 48202, USA.
Sub-Cellular Biochemistry
|August 30, 2008
Summary
Eicosanoids, bioactive metabolites, and their enzymes play crucial roles in physiological and disease processes. This review highlights their involvement in promoting solid tumor progression and metastasis.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Eicosanoids are bioactive lipid mediators derived from fatty acids.
- Enzymes like cyclooxygenases and lipoxygenases generate eicosanoids.
- These molecules are implicated in various physiological and pathological conditions, including inflammation and cancer.
Purpose of the Study:
- To review the role of eicosanoids and their synthesizing enzymes in cancer.
- To elucidate the pathways through which eicosanoids influence tumor initiation, progression, and metastasis.
Main Methods:
- Literature review of scientific studies on eicosanoids in cancer.
- Analysis of enzymatic pathways involved in eicosanoid generation.
- Summary of research on eicosanoid-mediated signaling in tumor biology.
Main Results:
- Eicosanoids contribute to tumor cell proliferation, survival, and angiogenesis.
- Specific eicosanoids promote invasion and metastasis by modulating the tumor microenvironment.
- Enzymes generating eicosanoids are often dysregulated in various cancers.
Conclusions:
- Eicosanoids and their enzymes represent critical targets for cancer therapy.
- Understanding eicosanoid pathways is essential for developing novel anti-cancer strategies.
- Targeting eicosanoid metabolism may inhibit tumor progression and metastasis.
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...